Concepedia

Ravi Goud

RG

Statistics

Publications

7

Citations

346

H-Index

7

Active since

2014

Affiliations

Center for Biologics Evaluation and Research(Current)

United States Food and Drug Administration

Acumen (United States)

Stanford University

Centers for Medicare and Medicaid Services

Ravi Goud is an author at Center for Biologics Evaluation and Research specializing in vaccination, vaccinology, and immunization.

Publications per year

2014–2021

7

Publications

7

Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)

Kerry J. Welsh, Jane Baumblatt, Wambui Chege et al. · Vaccine · 2021 · 146 citations · Full text

, , +16

Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries

Ravi Goud, Bradley Lufkin, Jonathan Duffy et al. · JAMA Internal Medicine · 2021 · 75 citations · Full text

, , +16

Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018

Elisabeth M. Hesse, Tom T. Shimabukuro, John R. Su et al. · MMWR Morbidity and Mortality Weekly Report · 2019 · 61 citations · Full text

, , +17

Decision support environment for medical product safety surveillance

Taxiarchis Botsis, Christopher Jankosky, Deepa Arya et al. · Journal of Biomedical Informatics · 2016 · 30 citations · Full text

, , +14

<i>Notes from the Field:</i> Vaccine Administration Errors Involving Recombinant Zoster Vaccine — United States, 2017–2018

Tom T. Shimabukuro, Elaine R. Miller, Raymond A. Strikas et al. · MMWR Morbidity and Mortality Weekly Report · 2018 · 12 citations · Full text

, , +12

1–5 of 7